Amend SB 269 (house committee report) by striking page 1, line 24 through page 2, line 2 and substituting the following:
(1) experimental or investigational;
(2) approved or authorized for emergency use by the United States Food and Drug Administration; or
(3) recommended for use by the Advisory Committee on Immunization Practices of the federal Centers for Disease Control and Prevention.